<?xml version="1.0" encoding="UTF-8"?>
<notes notes-type="author-contribution">
 <title>Author contributions</title>
 <p>J.W. and C.M. conceived and designed the study; C.M. expressed the M
  <sup>pro</sup> with the assistance of T.S.; C.M. performed the primary screening, secondary IC
  <sub>50</sub> determination, thermal shift binding assay, and enzymatic kinetic studies; M.D.S. carried out M
  <sup>pro</sup> crystallization and structure determination with the assistance of X.Z., and analyzed the data with Y.C.; B.H. and B.T. performed the SARS-CoV-2 CPE and VYR assays; J.A.T. performed the native mass spectrometry experiments with the guidance from M.T.M.; Y.H. performed the plaque reduction assay with influenza A/California/07/2009 (H1N1) virus; J.W. and Y.C. secured funding and supervised the study; J.W., Y.C., and C.M. wrote the paper with the input from others.
 </p>
</notes>
